PHARMADAX INC. Inactive Instrument
Pharmadax Inc. Stock
Equities
4191
TW0004191002
Biotechnology & Medical Research
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Hsing Mei Ti
DFI | Director of Finance/CFO | - | 16-10-31 |
Hui Ju Chan
PSD | President | - | 12-02-29 |
Su Hsia Liao
PRN | Corporate Officer/Principal | - | 10-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yao Tang Chung
BRD | Director/Board Member | - | 13-09-26 |
Hui Ju Chan
PSD | President | - | 12-02-29 |
Hung Chi Huang
BRD | Director/Board Member | - | 12-12-23 |
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
